All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Semaglutide and Fertility

Understand how semaglutide affects fertility in men and women, what the research shows, when to stop before trying to conceive, and key safety...

By Dr. Sarah Chen, PharmD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Sarah Chen, PharmD · Reviewed by Dr. David Kim, MD, FACE

Semaglutide and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Semaglutide and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Semaglutide and Fertility

Understand how semaglutide affects fertility in men and women, what the research shows, when to stop before trying to conceive, and key safety...

Short answer

Understand how semaglutide affects fertility in men and women, what the research shows, when to stop before trying to conceive, and key safety...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, hormone labs and monitoring

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Understand how semaglutide affects fertility in men and women, what the research shows, when to stop before trying to conceive, and key safety considerations.

Semaglutide isn't approved for use during pregnancy, and manufacturers recommend stopping it at least two months before attempting to conceive. But the weight loss semaglutide provides may actually improve fertility outcomes for patients with obesity-related reproductive challenges. The relationship between semaglutide and fertility is nuanced and depends on your individual situation.

As GLP-1 medications become more widely prescribed for weight management, questions about their impact on reproductive health have increased significantly. This is especially relevant for women of childbearing age, who represent a large portion of patients seeking weight loss treatment.

Why Semaglutide Should Be Stopped Before Pregnancy

Semaglutide has a long half-life of approximately seven days, meaning it stays active in the body well after the last injection. The prescribing information for both Ozempic and Wegovy recommends discontinuing semaglutide at least two months before a planned pregnancy.

Animal studies showed some evidence of embryo-fetal toxicity at high doses, including early pregnancy loss and developmental abnormalities. While these findings occurred at doses much higher than those used in humans, the precautionary recommendation stands because adequate human pregnancy data is limited.

How Weight Loss From Semaglutide May Improve Fertility

Obesity is one of the most common modifiable risk factors for infertility in both men and women. Excess body weight can disrupt hormonal balance, ovulation regularity, sperm quality, and the success rates of assisted reproduction. For a complete cost breakdown, see our affordable GLP-1 options.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Semaglutide and Fertility

For women, losing even 5% to 10% of body weight can:

  • Restore regular ovulation in patients with polycystic ovary syndrome (PCOS)
  • Improve hormonal profiles including estrogen, progesterone, and luteinizing hormone
  • Increase success rates of IVF and other fertility treatments
  • Reduce the risk of pregnancy complications like gestational diabetes and preeclampsia

For men, weight loss can improve testosterone levels, sperm count, and sperm motility. Some reproductive endocrinologists now recommend a period of weight loss with GLP-1 medication before fertility treatment, followed by an appropriate washout period.

Semaglutide and PCOS

Polycystic ovary syndrome affects an estimated 8% to 13% of women of reproductive age, and many of those affected also have insulin resistance and difficulty managing weight. Semaglutide's dual action on weight and blood sugar regulation may benefit women with PCOS by improving insulin sensitivity and promoting weight loss, both of which can help restore ovulatory cycles.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Some early research and clinical observations suggest that women on GLP-1 medications may experience a return of ovulation they did not expect, sometimes referred to informally as "Ozempic babies." This underscores the importance of using reliable contraception while on semaglutide if pregnancy isn't desired. semaglutide and PCOS

Contraception Considerations

Because GLP-1 medications slow gastric emptying, there's a theoretical concern that oral contraceptive absorption could be affected. The FDA has noted this possibility and some providers recommend using a non-oral backup method of contraception (such as an IUD, implant, or condoms) while taking semaglutide. Discuss your contraceptive method with your provider when starting semaglutide.

Male Fertility and Semaglutide

Research on semaglutide's direct effects on male fertility is limited. Animal studies haven't shown significant negative effects on male reproductive function at standard doses. The indirect benefit of weight loss improving testosterone and sperm quality may outweigh theoretical risks for many men. But men planning to conceive should also discuss the timeline with their provider.

Frequently Asked Questions

How long before trying to conceive should I stop semaglutide?

The manufacturer recommends stopping semaglutide at least two months before attempting to become pregnant. This allows the medication to fully clear your system given its approximately seven-day half-life. Your provider may adjust this timeline based on your individual circumstances.

Can semaglutide cause infertility?

There's no evidence that semaglutide causes permanent infertility in humans. The recommendation to stop before pregnancy is precautionary, based on animal studies showing embryo-fetal effects at high doses. In fact, the weight loss from semaglutide may improve fertility for patients with obesity-related reproductive issues.

What if I get pregnant while taking semaglutide?

If you discover you're pregnant while taking semaglutide, stop the medication and contact your healthcare provider immediately. While the risk from short-term early exposure isn't fully characterized in humans, prompt discontinuation is the standard recommendation.

Does semaglutide affect birth control pills?

Because semaglutide slows gastric emptying, there's a theoretical risk that it could reduce oral contraceptive absorption. Some providers recommend using a backup non-oral contraceptive method while on semaglutide. Discuss this with your prescriber to determine the best approach for you. GLP-1 drug interactions

Potentially, yes. Weight loss and improved insulin sensitivity from semaglutide can help restore regular ovulation in women with PCOS. Some reproductive endocrinologists recommend a period of weight loss with GLP-1 medications before fertility treatment, followed by a washout period before conception attempts.

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Semaglutide and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Semaglutide and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Understand how semaglutide affects fertility in men and women, what the research shows, when to stop before trying to conceive, and key safety considerations. The practical reason to read "Semaglutide and Fertility" is to separate useful context from easy claims about semaglutide, safety and pharmacy quality. It sits in a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision and should help with patient education and clinical context. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use the page to sharpen your next question, especially if your health history or medications change the risk profile.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Semaglutide and Fertility

Semaglutide and Fertility now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, testosterone, cash-pay pricing, safety signals, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to semaglutide and fertility.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Semaglutide and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Semaglutide and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Semaglutide and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Sarah Chen, PharmD

Clinical Pharmacist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.